Search Within

Urvi A Shah

  1. "Population Sciences Research Program"
Formats
  1. Meeting Abstract (55)
  2. Journal Article (12)
  3. Research Letter (5)
  4. Correspondence (1)
  5. Review (1)
Groups
  1. CTCR Scholars (74)
  2. Department of Medicine (74)
  3. Hematologic Malignancies, Division of (74)
  4. Population Sciences Research Program (74)
  5. Biostatistics Service (73)
  6. Epidemiology and Biostatistics (73)

More Groups

People
  1. Andriy Derkach (72)
  2. Alexander Lesokhin (69)
  3. Malin Hultcrantz (67)
  4. Hani Hassoun (65)
  5. Sham Mailankody (65)
  6. Carlyn Rose Tan (64)

More People

Years
  1. 2025 (1)
  2. 2024 (16)
  3. 2023 (20)
  4. 2022 (21)
  5. 2021 (9)
  6. 2020 (7)
Publications
  1. Blood (27)
  2. Clinical Lymphoma, Myeloma and Leukemia (19)
  3. Journal of Clinical Oncology (9)
  4. Blood Cancer Journal (4)
  5. American Journal of Hematology (2)
  6. Clinical Cancer Research (2)

More Publications

Publishers
  1. American Society of Hematology (28)
  2. Elsevier Inc. (20)
  3. American Society of Clinical Oncology (9)
  4. Nature Publishing Group (5)
  5. American Association for Cancer Research (3)
  6. American Medical Association (2)

More Publishers

Results (74)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Diagnosis disclosure patterns among patients with plasma cell disorders
    Meeting Abstract

    Malik, M.; Dalvi, A.; Derkach, A.; Aldana, A. M. S. S.; Martinez, J. A. H.; Merlo, G.; Ahlstrom, J. M.; Hydren, J. R.; Usmani, S. Z.; Chimonas, S.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Supplement use habits and perceptions in patients with plasma cell disorders
    Meeting Abstract

    Leyfman, Y.; Schach, E.; Derkach, A.; Castro, F.; Martínez, J. A. H.; Aldana, A. M. S. S.; Pérez, P. A. F.; Malik, M.; Ahlstrom, J. M.; Hydren, J. R.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Real-world schedule de-escalation of teclistamab in patients with relapsed/refractory multiple myeloma
    Meeting Abstract

    Tan, C. R. C.; Derkach, A.; Maclachlan, K.; Hultcrantz, M.; Hassoun, H.; Mailankody, S.; Shah, U. A.; Rajeeve, S.; Shah, G. L.; Scordo, M.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Clinical outcomes of retreatment with daratumumab-based regimens in anti-CD38 refractory multiple myeloma
    Meeting Abstract

    Tan, C. R. C.; Rueda, C.; Shekarkhand, T.; Derkach, A.; Korde, N.; Maclachlan, K.; Hultcrantz, M.; Hassoun, H.; Mailankody, S.; Shah, U. A.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Comparison of infectious complications with BCMA-directed therapies in multiple myeloma
    Journal Article

    Nath, K.; Shekarkhand, T.; Nemirovsky, D.; Derkach, A.; Costa, B. A.; Nishimura, N.; Farzana, T.; Rueda, C.; Chung, D. J.; Landau, H. J.; more...
    Blood Cancer Journal (2024)

    Fulltext@MSK | Save
  • Pre-diagnosis dietary patterns and risk of multiple myeloma in the NIH-AARP diet and health study
    Research Letter

    Castro, F.; Parikh, R.; Eustaquio, J. C.; Derkach, A.; Joseph, J. M.; Lesokhin, A. M.; Usmani, S. Z.; Shah, U. A.
    Leukemia (2024)

    Fulltext@MSK | Save
  • Prevalence and impact of diabetes on survival of patients with multiple myeloma in different racial groups
    Journal Article

    Shah, U. A.; Moshier, E.; Derkach, A.; Huang, Y.; Mailankody, S.; Tan, C. R.; Maclachlan, K.; Hultcrantz, M.; Korde, N.; Hassoun, H.; more...
    Blood Advances (2024)

    Fulltext@MSK | Save
  • Dietary patterns among individuals with plasma cell disorders compared to the general US population
    Meeting Abstract

    Traore, K.; Taneja, A.; Gorshein, E.; Castro, F.; Derkach, A.; Martinez, J. A. H.; Serrano, E.; Lesokhin, A.; Ahlstrom, J. M.; Block, T.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Daratumumab, bortezomib, lenalidomide, and dexamethasone (DVRd) and daratumumab, carfilzomib, lenalidomide and dexamethasone (DKRd) as induction therapy in newly diagnosed multiple myeloma
    Meeting Abstract

    Tan, C.; Maclachlan, K. H.; Nemirovsky, D.; Derkach, A.; Hultcrantz, M.; Hassoun, H.; Mailankody, S.; Shah, U. A.; Rajeeve, S.; Patel, D.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • T-cell exhaustion signature predicts early relapse after autologous stem cell transplant for multiple myeloma: BMT CTN 0702 secondary immune analysis
    Meeting Abstract

    Mehanna, N.; Derkach, A.; Gasmi, B.; Anagnostou, T.; Landau, H.; Lahoud, O. B.; Scordo, M.; Shah, G. L.; Hassoun, H.; Maclachlan, K. H.; more...
    Blood (2023)

    Fulltext@MSK | Save